🔥 Tune in to our new episode on maintenance therapy in #MultipleMyeloma with Hira Mian & Manni Mohyuddin ! We discuss a wide range of RCTs from CALGB to FORTE, ideal endpoints for maintenance trials, and role of MRD!
tinyurl.com/4mtjyz6m
Here is clip on Dara maint. in CASSIOPEIA!
Happy to report that Replay & MD Anderson Cancer Center received U.S. FDA clearance for the IND application of our first-in-class PRAME TCR-NK cell therapy PRAME TCR/IL-15 NK platform for #AML #MDS and #MultipleMyeloma , developed by our product company, #Syena .
replay.bio/news/replay-an…
Aaron Goodman and I draw attention to over treatment of multiple myeloma and its precursor states - Manni Mohyuddin
NatureRevClinOncol Aaron Goodman - “Papa Heme”
oncodaily.com/55787.html
#Cancer #ClinicalTrial #MultipleMyeloma #Nature #ClinicalOncology #OncoDaily #Oncology #UniversityOfUtah
Just two days until our workshop. Sign up today!
genomictestingcooperative.com/genomics-in-th…
#Hematology #AML #Leukemia #Multiplemyeloma
Ready to grow your #hematology knowledge? #EHAMasterclass 2024-2025 applications are open - apply before June 30 to discover cases on:
🔎 Pediatric hematology
🔎 #Hemophilia
🔎 #Multiplemyeloma
🔎 #Lymphoma
🔎 #thalassemia and #NTDT
Apply now: eha.fyi/MC_24/25
YoungEHA
Bispecific T-cell engagers (BiTEs) empower your immune system to fight #multiplemyeloma , connecting it to cancer cells and enhancing their destruction. Read more: mymyelomateam.com/resources/bisp…
Managing Multiple Myeloma: Reducing the Burden with Oral Therapies.
Discover how oral treatments are transforming care for patients: touchhaematology.com/your-free-10-m…
#MultipleMyeloma #OralTherapies #CancerCare
Thank you to our volunteers at Gibbons Run. #NonHodgkinsLymphoma #HodgkinsLymphoma #Leukemia #MultipleMyeloma [Video] A heartfelt thank you to all our amazing volunteers who pour their time, energy, and passion into making the ABC7 Gibbons Run a success.… dlvr.it/T6FKXL
📰This study published by Blood Cancer Journal, elucidates not only the importance of disease biology but also the role of management prior to apheresis.
READ➡️tinyurl.com/3yb2tt76
#MYELOMA #MultipleMyeloma #bloodcancer #hematology #MedTwitter #Oncology #Cancer #Cancer Research
Dr. Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰, Chief of Memorial Sloan Kettering Cancer Center's Myeloma Service, says there are far more treatment options for #multiplemyeloma today compared with just 20 years ago. Here's his vision for developing new treatment approaches at MSK: bit.ly/4a91C2q
Plasma cell leukemia with aggressive and aberrant plasma cells. #hemepath #PathTwitter #multiplemyeloma
The FDA recently approved 2 CAR T-cell therapies for earlier treatment of adults with multiple myeloma. Prior to these approvals, patients had to receive at least four lines of treatment before they were eligible for CAR T-cell therapy. bit.ly/3vZL3ar #Multiplemyeloma
📰In short summary, this study published by Blood Cancer Journal, concluded that patients with no-BT before ide-cel showed prolonged PFS & OS, possibly indicating less aggressive disease.
READ➡️tinyurl.com/2p9wc5aw
#MYELOMA #MultipleMyeloma #Oncology #hematology #CancerResearch
📢Great video🔛 #multiplemyeloma featuring Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 & colleagues, discussing complex, real🌐pt cases highlighting diagnostic & tx guidelines, clinical practice issues, clinical trial 📊& expert analysis of best practices
Watch➡️tinyurl.com/46fayd2e
#MedTwitter #myeloma #cancer
Curious about MARS®?
Stop by our BOOTH 1757 and check out our MARS® Platform during #ASGCT2024 in Baltimore, MD this May 7-10! Speak with our experts and explore the future of cell separation.
#CellTherapy #CancerResearch #Hematology #multiplemyeloma #genetherapy #Biotech
